Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hereditary ovarian cancer.

Jaime Prat1, Adriana Ribé, Alberto Gallardo

  • 1Department of Pathology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, 08025 Barcelona, Spain. jprat@santpau.es

Human Pathology
|August 23, 2005
PubMed
Summary

Family history strongly predicts ovarian cancer risk. Hereditary ovarian cancers, often linked to BRCA or Lynch II (HNPCC) gene mutations, present unique features and better outcomes than sporadic types.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mullerian adenosarcoma of the uterus, ovary and peritoneum: Whole transcriptomic digital spatial profiling (DSP) in a cohort of 42 tumors.

Human pathology·2026
Same author

Subcutaneous administration of an endocrine-mimetic platform allows for prolonged tumor uptake of a tumor targeting protein.

International journal of pharmaceutics·2026
Same author

PM534, a Novel Colchicine Site Tubulin Inhibitor with Broad-Spectrum and Resistance-Overcoming Antitumor Activity.

Molecular cancer therapeutics·2026
Same author

Effect of Polyurethane Structure on the Physicochemical, Mechanical, and Biological Properties on their Copper Complexes Composites.

Macromolecular bioscience·2025
Same author

Nanotoxin induces in situ pyroptosis to sensitize αPD1 to ablate metastases in microsattellite stable colorectal cancer.

Pharmacological research·2025
Same author

Design of Vitrimers with Simultaneous Degradable and Dynamic Crosslinkers: Mechanical and Thermal Behavior Based on Transesterification Reactions Between <i>β</i>-Amino Esters and Hydroxylated Acrylate/Methacrylate Monomers.

Polymers·2025

Area of Science:

  • Oncology
  • Genetics
  • Cancer Research

Background:

  • Family history is the most significant risk factor for ovarian cancer.
  • Hereditary ovarian cancer manifests in distinct syndromes: site-specific, breast and ovarian cancer syndrome (BRCA1/BRCA2 mutations), and hereditary nonpolyposis colorectal cancer (HNPCC/Lynch II syndrome; MMR gene mutations).

Purpose of the Study:

  • To outline the genetic basis, clinicopathologic features, and outcomes of hereditary ovarian cancers.
  • To differentiate hereditary from sporadic ovarian cancers and inform management strategies.

Main Methods:

  • Review of clinical manifestations and genetic associations of hereditary ovarian cancer.
  • Analysis of clinicopathologic features, risk factors, and outcomes associated with BRCA1, BRCA2, and HNPCC mutations.

Main Results:

  • Hereditary ovarian cancers account for at least 10% of epithelial cases, primarily due to BRCA mutations (approx. 90%) and HNPCC (approx. 10%).
  • BRCA1/BRCA2 mutations confer high lifetime risks (40-50% for BRCA1, 20-30% for BRCA2) and are associated with younger age at diagnosis, high-grade serous carcinomas, and better outcomes.
  • HNPCC-associated ovarian cancer has a >12% cumulative risk, occurs at younger ages, and presents as lower-stage, well-differentiated tumors.

Conclusions:

  • Hereditary ovarian cancers, driven by BRCA or MMR gene mutations, have distinct features and improved prognosis compared to sporadic forms.
  • Prophylactic oophorectomy is recommended for high-risk women, and annual surveillance is advised for HNPCC families.

Related Experiment Videos